XML 23 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2022   362,300,000        
Beginning balance at Dec. 31, 2022 $ 6,821.3 $ 3.6 $ 3,138.5 $ 3,401.1 $ (322.2) $ 600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (6,505,037) (6,500,000)        
Shares repurchased $ (203.7)     (203.7)    
Net shares issued for equity-based awards (in shares)   4,900,000        
Equity-based compensation 192.3   192.3      
Deconsolidation of a Consolidated Entity (110.4)         (110.4)
Dividend-equivalent rights on certain equity-based awards 0.0   7.0 (7.0)    
Contributions 99.0         99.0
Dividends and distributions (471.1)     (371.4)   (99.7)
Net income (loss) 173.6     83.6   90.0
Currency translation adjustments 4.9       (0.6) 5.5
Defined benefit plans, net (1.1)       (1.1)  
Ending balance (in shares) at Sep. 30, 2023   360,700,000        
Ending balance at Sep. 30, 2023 6,504.8 $ 3.6 3,337.8 2,902.6 (323.9) 584.7
Beginning balance (in shares) at Jun. 30, 2023   360,000,000.0        
Beginning balance at Jun. 30, 2023 $ 6,644.6 $ 3.6 3,266.5 2,992.9 (299.3) 680.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (1,343,419) (1,300,000)        
Shares repurchased $ (42.9)     (42.9)    
Net shares issued for equity-based awards (in shares)   2,000,000.0        
Equity-based compensation 68.9   68.9      
Deconsolidation of a Consolidated Entity (103.3)         (103.3)
Dividend-equivalent rights on certain equity-based awards 0.0   2.4 (2.4)    
Contributions 43.5         43.5
Dividends and distributions (191.9)     (126.3)   (65.6)
Net income (loss) 111.0     81.3   29.7
Currency translation adjustments (24.1)       (23.6) (0.5)
Defined benefit plans, net (1.0)       (1.0)  
Ending balance (in shares) at Sep. 30, 2023   360,700,000        
Ending balance at Sep. 30, 2023 $ 6,504.8 $ 3.6 3,337.8 2,902.6 (323.9) 584.7
Beginning balance (in shares) at Dec. 31, 2023 361,326,172 361,300,000        
Beginning balance at Dec. 31, 2023 $ 5,784.5 $ 3.6 3,403.0 2,082.1 (297.3) 593.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (8,029,148) (8,000,000.0)        
Shares repurchased $ (345.7) $ (0.1)   (345.6)    
Net shares issued for equity-based awards (in shares)   4,400,000        
Net shares issued for equity-based awards (133.2)     (133.2)    
Equity-based compensation 362.0 $ 0.1 361.9      
Dividend-equivalent rights on certain equity-based awards 0.0   9.6 (9.6)    
Contributions 219.2         219.2
Dividends and distributions (450.8)     (377.8)   (73.0)
Net income (loss) 863.8     809.5   54.3
Currency translation adjustments 34.8       30.6 4.2
Change in ownership interests of a Consolidated Entity 0.0     9.1   (9.1)
Defined benefit plans, net $ 0.8       0.8  
Ending balance (in shares) at Sep. 30, 2024 357,681,261 357,700,000        
Ending balance at Sep. 30, 2024 $ 6,335.4 $ 3.6 3,774.5 2,034.5 (265.9) 788.7
Beginning balance (in shares) at Jun. 30, 2024   356,400,000        
Beginning balance at Jun. 30, 2024 $ 5,729.4 $ 3.6 3,642.6 1,707.7 (324.0) 699.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (1,670,245) (1,700,000)        
Shares repurchased $ (63.4) $ (0.1)   (63.3)    
Net shares issued for equity-based awards (in shares)   3,000,000.0        
Net shares issued for equity-based awards (85.5)     (85.5)    
Equity-based compensation 128.3 $ 0.1 128.2      
Dividend-equivalent rights on certain equity-based awards 0.0   3.7 (3.7)    
Contributions 98.8         98.8
Dividends and distributions (152.9)     (125.5)   (27.4)
Net income (loss) 615.7     595.7   20.0
Currency translation adjustments 64.7       57.8 6.9
Change in ownership interests of a Consolidated Entity 0.0     9.1   (9.1)
Defined benefit plans, net $ 0.3       0.3  
Ending balance (in shares) at Sep. 30, 2024 357,681,261 357,700,000        
Ending balance at Sep. 30, 2024 $ 6,335.4 $ 3.6 $ 3,774.5 $ 2,034.5 $ (265.9) $ 788.7